| FXO | PFI | FXO / PFI | |
| Gain YTD | 10.495 | 9.207 | 114% |
| Net Assets | 1.13B | 59.3M | 1,904% |
| Total Expense Ratio | 0.60 | 0.60 | 100% |
| Turnover | 90.00 | 153.00 | 59% |
| Yield | 1.99 | 0.98 | 203% |
| Fund Existence | 19 years | 20 years | - |
| FXO | PFI | |
|---|---|---|
| RSI ODDS (%) | 4 days ago 85% | 4 days ago 86% |
| Stochastic ODDS (%) | 4 days ago 80% | 4 days ago 86% |
| Momentum ODDS (%) | 4 days ago 84% | 4 days ago 76% |
| MACD ODDS (%) | 4 days ago 84% | 4 days ago 75% |
| TrendWeek ODDS (%) | 4 days ago 84% | 4 days ago 84% |
| TrendMonth ODDS (%) | 4 days ago 82% | 4 days ago 83% |
| Advances ODDS (%) | 7 days ago 85% | 4 days ago 83% |
| Declines ODDS (%) | 4 days ago 80% | N/A |
| BollingerBands ODDS (%) | 4 days ago 83% | 4 days ago 78% |
| Aroon ODDS (%) | 4 days ago 80% | 4 days ago 75% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| RERHX | 62.33 | 0.41 | +0.66% |
| American Funds EUPAC R-5E | |||
| ETIDX | 21.88 | 0.09 | +0.41% |
| Eventide Dividend Growth I | |||
| GMVAX | 19.01 | 0.04 | +0.21% |
| Goldman Sachs Small/Mid Cap Equity A | |||
| PRDMX | 47.50 | -0.11 | -0.23% |
| T. Rowe Price Diversified Mid Cap Gr | |||
| ICMPX | 16.91 | -0.27 | -1.57% |
| Lazard International Quality Gr Instl | |||
A.I.dvisor indicates that over the last year, FXO has been closely correlated with ASB. These tickers have moved in lockstep 85% of the time. This A.I.-generated data suggests there is a high statistical probability that if FXO jumps, then ASB could also see price increases.
A.I.dvisor indicates that over the last year, PFI has been closely correlated with PFG. These tickers have moved in lockstep 81% of the time. This A.I.-generated data suggests there is a high statistical probability that if PFI jumps, then PFG could also see price increases.